Rapt with MSB's performance today. Must admit I did not expect that this quickly. I like the manufacturing agreement. As I understand it, manufacturing is one of the sticking points with the FDA so if they have an agreement in place which will hopefully address some of the FDA concerns, that has to be a big plus. Also Novartis intends to initiate a Phase 3 study in non-COVID-19-related ARDS, which is another bonus. It's been quite a roller coaster this year.
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 23 Nov
Rapt with MSB's performance today. Must admit I did not expect...
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online